ROBERT NEWTON BREY

Summary

Publications

  1. ncbi Molecular basis for improved anthrax vaccines
    Robert N Brey
    DOR BioPharma, Inc, 1691 Michigan Avenue, Suite 435, Miami, FL 33139, USA
    Adv Drug Deliv Rev 57:1266-92. 2005

Research Grants

  1. MICROSPHERE VACCINE AGAINST AEROSOLIZED RICIN TOXIN
    Robert Brey; Fiscal Year: 2003
  2. DEVELOPMENT OF A RECOMBINANT VACCINE FOR RICIN TOXIN
    Robert Brey; Fiscal Year: 2004
  3. Development of a mucosally administered trivalent serotype A,B, E botulinum va
    Robert Brey; Fiscal Year: 2006
  4. ORAL BDP FOR THE TREATMENT OF GI GVHD
    Robert Brey; Fiscal Year: 2005
  5. Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin Toxin
    Robert Brey; Fiscal Year: 2007

Detail Information

Publications1

  1. ncbi Molecular basis for improved anthrax vaccines
    Robert N Brey
    DOR BioPharma, Inc, 1691 Michigan Avenue, Suite 435, Miami, FL 33139, USA
    Adv Drug Deliv Rev 57:1266-92. 2005
    ..The next generation anthrax vaccines will be derived from the thorough understanding of the interaction of virulence factors with human and animal hosts and the role the immune response plays in providing protective immunity...

Research Grants6

  1. MICROSPHERE VACCINE AGAINST AEROSOLIZED RICIN TOXIN
    Robert Brey; Fiscal Year: 2003
    ..abstract_text> ..
  2. DEVELOPMENT OF A RECOMBINANT VACCINE FOR RICIN TOXIN
    Robert Brey; Fiscal Year: 2004
    ..Preservation of the polypeptide structure during storage of the vaccine will also be addressed by formulating the vaccine candidate in protein stabilizinq recipients. ..
  3. Development of a mucosally administered trivalent serotype A,B, E botulinum va
    Robert Brey; Fiscal Year: 2006
    ..At the end of Phase II, we expect to have identified a vaccine to advance to clinical studies. ..
  4. ORAL BDP FOR THE TREATMENT OF GI GVHD
    Robert Brey; Fiscal Year: 2005
    ..Abstract Not Provided ..
  5. Continued Development of a Recombinant Vaccine (RivaxTM) against Ricin Toxin
    Robert Brey; Fiscal Year: 2007
    ..A safe and effective FDA-approved vaccine is urgently needed for military personnel and, in the event of a domestic attack, for first responders and perhaps for the general public. ..